Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease

In order toevaluate the influence of the metabolic syndrome (MS) (obesity, hypertension, elevated triglycerides, reduced levels of HDL cholesterol and glucose impairment) on the phenotype of LRRK2 and GBA Parkinson’s disease (PD), and on the prevalence of prodromal features among individuals at risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaler, Avner, Shenhar-Tsarfaty, Shani, Shaked, Yanay, Gurevich, Tanya, Omer, Nurit, Bar-Shira, Anat, Gana-Weisz, Mali, Goldstein, Orly, Kestenbaum, Meir, Cedarbaum, Jesse M., Orr-Urtreger, Avi, Giladi, Nir, Mirelman, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283235/
https://www.ncbi.nlm.nih.gov/pubmed/32518334
http://dx.doi.org/10.1038/s41598-020-66319-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283235/
https://www.ncbi.nlm.nih.gov/pubmed/32518334
http://dx.doi.org/10.1038/s41598-020-66319-9

Ejemplares similares